drugset / Trial / NCT00661479
An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa
Non-randomizedSingle-groupSingle-blindTreatment
Summary
This exploratory, 12-month, ascending-dose study will evaluate the safety and effects on visual function of a single injection of Brimonidine intravitreal implant in one eye of patients with Retinitis Pigmentosa.
Timeline
- Start
- 2008-07
- Primary completion
- 2009-12
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brimonidine | Small molecule | 100 ug | Intravitreal |
| Subject | Brimonidine | Small molecule | 200 ug | Intravitreal |
| Subject | Brimonidine | Small molecule | 400 ug | Intravitreal |